Transcranial Magnetic Stimulation (TMS) trials

Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomi

RecruitingNCT07581756Phase: NAStarted 2024-12-01

Summary

Objectives: This study aims to evaluate the clinical efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) in patients with diarrhea-predominant irritable bowel syndrome (IBS-D),

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
70 Years

Locations

The First Affiliated Hospital of Soochow UniversitySuzhou, Jiangsu, China

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT07581756